KLF6 has been previously shown to be expressed in lymphoid cells[44, 45] and, similarly to SPATS2L, there is also evidence of differential expression of KLF6 in T cells from CLL patients compared to controls[46]. Here, SPATS2L is linked to B-cell chronic lymphocytic leukemia.